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Abstract
Hypocalcemic cardiomyopathy due to hypoparathyroidism is a very atypical and rare 
circumstance, which is usually intractable to conventional therapy for cardiac failure, but 
responds satisfactorily to restoration of normocalcemia.
We describe a young woman who developed clinical signs of hypocalcemia due to 
hypoparathyroidism, reduced left ventricular ejection fraction and polymorphic ventricular 
tachycardia as consequences of hypocalcemia.
This case underscores the importance of biochemical abnormalities like hypocalcemia as 
a rare cause of secondary cardiomyopathy and emphasizes on the need for effective and 
immediate treatment of hypocalcemia and its related causes.
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Dilated cardiomyopathy could be primary or secondary. 
Even if some causes are familiar, such as toxic agents (alcohol 
or drugs of chemotherapy) or viral and bacterial infections, 
biochemical abnormalities are much less common [1]. Hy-
pocalcemia diminishes myocardial contractility and results in 
left ventricular systolic dysfunction [2].
In this paper, we report a case of heart failure with hypocalce-
mia and primary hypoparathyroidism which was treated with 
vitamin D and calcium supplement.
CASE PRESENTATION
A 21-year-old female was admitted to our emergency depart-
ment due to worsening dyspnea (NYHA class III) for seven 
days. Her past medical history was significant for primary 
hypoparathyroidism from six years ago, but she discontinued 
her regular medication (oral calcium and vitamin D) from 
three months. Moreover, she complained about numbness of 
both hands and feet for two months.
On physical examination, blood pressure was 100/65 mmHg, 
heart rate was 78 beats per minute, respiratory rate was 16 
breaths per minute, and body temperature was 36.8◦C. Ch-
vostek’s and Trousseau’s signs were positive. On auscultation 
of the chest, there were coarse fine rales on the base of both 
lung fields, and grade III systolic murmur on apex and left 
sternal border were heard. The reminder of her physical ex-
amination was unremarkable.
Her electrocardiogram (ECG) showed normal sinus rhythm 
with T wave inversion in the precordial leads and prolonged 
QTc interval (520 msec). The transthoracic echocardiogra-
phy demonstrated global hypokinesia of the LV with 13% left 
ventricular ejection fraction (EF), moderate diastolic dys-
function and mild mitral regurgitation (Fig 1). Chest radiog-
raphy revealed cardiomegaly. Perfusion stress test revealed no 
signs of ischemia.
Laboratory studies revealed the following: magnesium 1.5 
mg/dL (reference range: 1.6-3.0 mg/dL), albumin 4.2 g/
dL (reference range: 3-5.5 mg/dL), corrected calcium 7 mg/
dL (reference range: 8.6-10 mg/dL), phosphate 10.1 mg/dL 
(reference range: 2.5-5 mg/dL), and intact parathyroid hor-
mone (PTH-I) 6 pg/mL (reference range: 15-65 pg/mL). 
CK-MB, cardiac troponin I, complete blood count, blood 
urea nitrogen (BUN), serum creatinine, blood glucose, Na+, 
K+, alanine aminotransferase (SGOT), aspartate amino-
transferase (SGPT), alkaline phosphatase, bilirubin, T3, T4 
and TSH were within normal ranges. Viral markers and full 
panel of rheumatology studies for autoimmune antibodies 
were all negative. 
At the first night of her admission, she developed abnormal 
tonic movement, loss of consciousness and episode of poly-
morphic ventricular tachycardia (Fig 2), which was con-
trolled with asynchronized 200 J shock. Treatment initiated 
with administration of furosemide, captopril, digitalis and 
spironolactone. In addition, calcium, magnesium and vita-
min D were added to her drug regimen.
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Following normalization of her calcium level, she was dis-
charged after five days under the treatment of oral calcium, vi-
tamin D3, furosemide, carvedilol and captopril. Her ejection 
fraction at the time of discharge was 36%. She was planned 
for follow-up transthoracic echocardiography for evaluation 
of the cardiac function as well as for close observation of car-
diology and endocrinology clinics.
Figure 1: Transthoracic Echocardiography Demonstrated Global 
Hypokinesia of the LV with 13% of Left Ventricular Ejection Frac-
tion, Which Was Measured by Biplane Simpson Method
Figure 2: Polymorphic Ventricular Tachycardia Developed at the 
Night of the Admission
DISCUSSION
Hypocalcemia is a very unusual reversible cause of dilated 
cardiomyopathy, which can involve one or both ventricles. 
Hypocalcemia diminishes myocardial contractility, but the 
prevalence of congestive heart failure due to hypocalcemia 
is uncommon [2, 3]. Hypocalcemic cardiomyopathy due to 
hypoparathyroidism is a very atypical circumstance which 
is usually intractable to conventional therapy for cardiac 
failure, but responds satisfactorily to restoration of normo-
calcemia [4, 5].
Ionized calcium has an essential task for regulating myocar-
dial contraction. During the cardiac action potential, ion-
ized calcium enters the cells through depolarization-acti-
vated calcium channels. The entered ionized calcium elicits 
calcium release from the sarcoplasmic reticulum. Ca2+ binds 
to myofilaments proteins such as troponin C, commencing 
contraction of myocardium [6, 7].
Hypocalcemia results in not only heart failure, but also ST 
segment changes in ECG, which mimic acute myocardial 
ischemia and infarction; it may lead to life threatening cardi-
ac arrhythmia like polymorphic ventricular tachycardia [8]. 
The hemodynamic and echocardiographic improvement 
of hypocalcemic cardiomyopathy could not be attained by 
usual medical treatments of heart failure [9].
The roles of calcium and vitamin D are pivotal in the treat-
ment of hypocalcemic cardiomyopathy; but, it has been 
also emphasized on the impending role of parathyroid hor-
mone (PTH) in preserving myocardial contractility [10].
Correction of serum level of calcium was not adequate for 
restitution of myocardial function. Rather, re-establishment 
of intracellular calcium level is thought to be more essen-
tial to returning myocardial function. It would take several 
months to normalized tissue calcium level [11]. Although 
cardiac function usually returns to normal status, there are 
some reports of persistent systolic dysfunction after vitamin 
D-calcium supplementation [12, 13]. There was no obvious 
cause for dilated cardiomyopathy in our case. Hypocalce-
mia was the lone probable cause, according to the pervious 
unusual case reports. 
This case underscores the importance of biochemical ab-
normalities like hypocalcemia as a rare cause of secondary 
cardiomyopathy and emphasizes on the need for effective 
and immediate treatment of hypocalcemia and its related 
causes.
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